1 It has previously been shown that the antimigraine drug sumatriptan constricts porcine carotid arteriovenous anastomoses via 5-HT 1 -like receptors, identical to 5-HT 1B/1D receptors. The recent availability of silent antagonists selective for the 5-HT 1B (SB224289) and 5-HT 1D (BRL15572) receptor led us to further analyse the nature of receptors involved. 
Introduction
It has previously been shown in several species that 5-HT causes constriction within the carotid vascular bed predominantly via 5-HT 1 -like receptors and this eect is potently mimicked by the antimigraine drug, sumatriptan (Den Boer et al., 1991; VillaloÂ n et al., 1995) . The carotid vasoconstrictor eect of sumatriptan and other acutely acting antimigraine agents is exclusively due to vasoconstriction of carotid arteriovenous anastomoses (see Saxena et al., 1997b; De Vries et al., 1999) , which may open up during migraine headaches (Heyck, 1969; Saxena, 1995) . Since sumatriptan displayed high anity at the 5-HT 1D receptor binding sites identi®ed in calf and human caudate membranes (see Hoyer et al., 1994; Martin, 1994) , it was suggested that`5-HT 1D ' receptors were responsible for the sumatriptan-induced carotid vasoconstriction. Presently, we know that the experimental conditions in the above experiments allowed the inclusion of 5-HT 1B , 5-HT 1D as well as 5-ht 1F receptors (see Saxena et al., 1998) . GR127935 (N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4' (5-methyl-1, 2,4-oxadiazol-3-yl) [1,1,-biphenyl]-4-carboxamide hydrochloride monohydrate), the ®rst potent and selective antagonist at the`5-HT 1D ' receptor (Clitherow et al., 1994; Pauwels, 1996; Skingle et al., 1996) , was shown to inhibit the sumatriptan-induced carotid vasoconstriction in pigs (De Vries et al., 1996) and dogs (VillaloÂ n et al., 1996) . In the mean time, it was demonstrated that the human 5-HT 1D receptor was encoded by two structurally distinct genes, named 5-HT 1Da and 5-HT 1Db (Weinshank et al., 1992) . The 5-HT 1Da receptor was shown to be the human homologue of the rat 5-HT 1B receptor and, consequently, renamed 5-HT 1B , while the 5-HT 1Da receptor was renamed 5-HT 1D receptor (see Hartig et al., 1996) . Unfortunately, GR127935 was not able to distinguish between these 5-HT 1B and 5-HT 1D receptors (Table  1) . Recently, however, two new potent compounds were developed, SB224289 (2,3,6,7-tetrahydro-1'-methyl-5-[2'-methyl-4'(5-methyl-1,2,4-oxadiazol-3-yl) biphenyl-4-carbonyl] furo [2,3-f] indole-3-spiro-4'-piperidine hydrochloride; Gaster et al., 1998) and BRL15572 (1-(3-chlorophenyl)-4-[3,3-diphenyl (2-(S,R) hydroxypropanyl) piperazine] hydrochloride; Price et al., 1997) , which show a high degree of selectivity for the 5-HT 1B and 5-HT 1D receptor, respectively (Table 1) . Using these compounds, it was shown that sumatriptan-induced canine external carotid vasoconstriction (De Vries et al., 1998a) and human isolated temporal artery contraction (Verheggen et al., 1998) as well as hypothermia induced by SKF-99101H (3-(2-dimethylaminoethyl)-4-chloro-5-propox-yindole hemifumarate) in the guinea-pig (Hagan et al., 1997) are mediated by SB224289-sensitive 5-HT 1B receptors, whereas the human atrium heteroreceptor resembles BRL15572-sensitive 5-HT 1D receptors (Schlicker et al., 1997) . In the light of the availability of the above selective ligands, we decided to verify whether 5-HT 1B or 5-HT 1D receptors are involved in the constriction of carotid arteriovenous anastomoses in anaesthetized pigs by the antimigraine drug, sumatriptan.
Methods

General
After an overnight fast, 21 pigs (Yorkshire x Landrace; 10 ± 15 kg) were anaesthetized with azaperone (160 mg, i.m.), midazolan hydrochloride (5 mg, i.m.) and pentobarbitone sodium (600 mg, i.v.), intubated and connected to a respirator (BEAR 2E, BeMeds AG, Baar, Switzerland) for intermittent positive pressure ventilation with a mixture of room air and oxygen. Respiratory rate, tidal volume and oxygen supply were adjusted to keep arterial blood gas values within physiological limits (pH: 7.35 ± 7.48; pCO 2 : 35 ± 48 mmHg; pO 2 :100 ± 120 mmHg). Anaesthesia was maintained with a continuous i.v. infusion of pentobarbitone sodium at 20 mg kg 71 min
71
. With this anaesthetic regimen, arteriovenous anastomotic blood¯ow is considerably higher than that in pigs in a conscious state or under thiopentone anaesthesia (Den Boer et al., 1993) , thereby producing one of the main putative features of migraine, i.e. vasodilatation of carotid arteriovenous anastomoses (see Heyck, 1969; Saxena, 1995) .
Catheters were placed in the inferior vena cava via the left femoral vein for the administration of drugs and in the aortic arch via the left femoral artery for the measurement of arterial blood pressure (Combitrans disposable pressure transducer; Braun, Melsungen, Germany) and the withdrawal of arterial blood for determining blood gases (ABL-510, Radiometer, Copenhagen, Denmark). The common carotid arteries, external jugular veins and vagus nerves were identi®ed and both vagi and the accompanying cervical sympathetic nerves were cut between two ligatures, in order to avoid re¯ex-mediated changes in the carotid vasculature. Another catheter was placed in the right external jugular vein for the withdrawal of venous blood samples, while the right common carotid artery was dissected free and a needle was inserted against the direction of blood¯ow for the administration and uniform mixing of radioactive microspheres. Blood¯ow was measured in the right common carotid artery with a¯ow probe (internal diameter: 2.5 mm) connected to a sine-wave electromagnetic ow meter (Trans¯ow 601-system, Skalar, Delft, The Netherlands). Heart rate was measured with a tachograph (CRW, Erasmus University, Rotterdam, The Netherlands) triggered by electrocardiographic signals.
Arterial blood pressure, heart rate and carotid blood¯ow were continuously monitored on a polygraph (CRW, Erasmus University, Rotterdam, The Netherlands). Body temperature was kept at about 378C and the animals were continuously infused with saline to compensate for¯uid losses during the experiment. The Ethics Committee of the Erasmus University Rotterdam dealing with the use of animals in scienti®c experiments approved the protocol for this investigation. Sc (NEN Dupont, Boston, U.S.A.). For each measurement a suspension of about 200,000 microspheres, labelled with one of the isotopes, was mixed and injected into the carotid artery. At the end of the experiment, the animal was killed, using an overdose of pentobarbitone sodium, and the heart, kidneys, lungs and the dierent cranial tissues were dissected out, weighed and put in vials. The radioactivity in these vials was counted for 5 min in a g-scintillation counter (Packard, Minaxi autogamma 5000), using suitable windows for discriminating the dierent isotopes ( Sc: 830 ± 965 KeV). All data were processed by a set of specially designed programs (Saxena et al., 1980) , using a personal computer.
Distribution of carotid blood¯ow
The fraction of carotid blood¯ow distributed to the dierent tissues was calculated by multiplying the ratio of tissue and total radioactivities by the total common carotid blood¯ow at the time of the injection of microspheres. Since little or no radioactivity was detected in the heart and kidneys, all microspheres trapped in lungs reached this tissue from the venous side after escaping via carotid arteriovenous anastomoses. Therefore, the amount of radioactivity in the lungs was used as an index of the arteriovenous anastomotic fraction of carotid blood¯ow (Saxena & Verdouw, 1982) . Vascular conductance was calculated by dividing blood¯ow (ml min 71 ) by blood pressure (mmHg), multiplied by hundred and expressed as 10 72 ml min 71 mmHg 71 .
Experimental protocol
After a stabilization period of about 1 h, baseline values of heart rate, mean arterial blood pressure, carotid blood¯ow and its distribution, as well as arterial and jugular venous blood gases were determined. At this point the animals were divided into four groups, receiving an i.v. infusion (1 ml min 71 over a period of 5 min) of either vehicle (distilled water, 20% propylene glycol, v v 71 ; n=6), SB224289 (1 mg kg
71
; n=6), SB224289 (3 mg kg 71 ; n=3) or BRL15572 (1 mg kg 71 ; n=6). After a waiting period of 15 min, all parameters were reassessed. Subsequently, sequential i.v. doses of sumatriptan (30, 100 and 300 mg kg 71 ) were given to all animals every 20 min. Fifteen minutes after each dose of sumatriptan, all haemodynamic variables were assessed again. In the group treated with 3 mg kg 71 of SB224289, i.v. bolus injections of noradrenaline (0.1, 0.3, 1 and 3 mg kg 71 ) were given at the start of the experiment (before SB224289) and at the end of the experiment (after SB224289 and the three doses of sumatriptan).
Data presentation and statistical analysis
All data have been expressed as mean+s.e.mean. The signi®cance of the dierence between the variables within one group was evaluated with Duncan's new multiple range test, once an analysis of variance (randomized block design) had revealed that the samples represented dierent populations (Steel & Torrie, 1980) . The per cent changes caused by sumatriptan in animals treated with SB224289 or BRL15572 were compared to the corresponding responses in animals treated with vehicle by using Student's unpaired t-test. The peak changes induced by noradrenaline before and after 3 mg kg 71 of SB224289 were compared by Student's paired ttest. Statistical signi®cance was accepted at P50.05 (twotailed).
Drugs
Apart from the anaesthetics, azaperone (Janssen Pharmaceuticals, Beerse, Belgium), midazolan hydrochloride (Homann La Roche b.v., Mijdrecht, The Netherlands) and pentobarbitone sodium (Apharmo, Arnhem, The Netherlands), the compounds used in this study were: sumatriptan succinate (gift from Dr H.E. Connor, Glaxo Group Research, Stevenage, Hertfordshire, U.K.), SB224289 and BRL15572 
5-HT
1B receptors in the porcine carotid vascular bed(both gifts from Dr A.A. Parsons, SmithKline Beecham Pharmaceuticals, Harlow, Essex, U.K.) and noradrenaline
Results
Systemic and carotid haemodynamic eects by vehicle, SB224289 or BRL15572
The eects of the two antagonists and vehicle on systemic (mean arterial blood pressure and heart rate) and carotid (total, arteriovenous anastomotic and nutrient vascular conductances and the dierence between oxygen saturation of arterial and jugular venous blood; A-V SO 2 ) are shown in Table 2 . Except for a moderate, but signi®cant increase in mean arterial blood pressure (12+2%) and decrease in carotid arteriovenous anastomotic conductance (21+5%) after the 1 mg kg 71 , i.v. dose of SB224289, there were no changes in these variables.
Systemic haemodynamic eects of sumatriptan in pigs treated with vehicle, SB224289 or BRL15572
Systemic haemodynamic changes induced by sumatriptan in the four dierent treatment groups are depicted in Table 3 . In vehicle-treated animals, sumatriptan slightly decreased heart rate (maximum decrease: 4+1%) and blood pressure (maximum decrease: 7+3%). The sumatriptan-induced bradycardia was not aected by treatment with either SB224289 (maximum decreases after 1 or 3 mg kg 71 : 5+1% or 4+1%, respectively) or BRL15572 (maximum decrease: 5+2%). On the other hand, after treatment with 1 mg kg 71 of SB224289, sumatriptan produced a signi®cantly more pronounced hypotension (maximum decrease: 19+3%). Similarly, 3 mg kg 71 of SB224289 signi®cantly potentiated the hypotension induced by 30 and 100 mg kg 71 of sumatriptan. Treatment with BRL15572 (1 mg kg 71 ) did not aect the sumatriptan-induced decrease in blood pressure (maximum decrease: 7+5%).
Sumatriptan dose-dependently increased A-V SO 2 by up to 270+71%. The increases in A-V SO 2 by sumatriptan were not signi®cantly modi®ed by treatment with 1 mg kg 71 of SB224289 or BRL15572 (maximum increases: 161+55 and 151+38%, respectively), whereas after 3 mg kg 71 of SB224289 this eect was absent.
Carotid haemodynamic eects of sumatriptan in pigs treated with vehicle, SB224289 or BRL15572
Changes in carotid haemodynamics by sumatriptan in the four dierent groups are depicted in Figures 1 (absolute values) and 2 (per cent changes). In vehicle-treated animals, sumatriptan dose-dependently decreased total carotid blood ow and conductance by up to 44+7% and 40+7%, respectively, accompanied by decreases in arteriovenous anastomotic blood¯ow and conductance by up to 72+4% and 70+5%, respectively. Nutrient blood¯ow and conductance increased after sumatriptan by up to 55+25% and 5-HT 1B receptors in the porcine carotid vascular bed65+26%, respectively. These eects of sumatriptan were dose-dependently reduced by SB224289. Thus, in animals treated with 1 mg kg 71 of SB224289 the sumatriptan-induced decreases in total carotid blood¯ow and conductance amounted to only 32+6% and 17+7%, respectively, while carotid arteriovenous anastomotic blood¯ow and conductance decreased by only up to 43+9% and 30+11%, respectively. After the higher dose (3 mg kg 71 ) of SB224289, the sumatriptan-induced maximal decreases in total carotid and arteriovenous anastomotic blood¯ows (12+7% and 18+3%, respectively) and conductances (4+12% and 3+7%, respectively) were completely blocked. Treatment with BRL15572 (1 mg kg 71 ) did not aect the sumatriptaninduced decreases in total carotid and arteriovenous anastomotic blood¯ows (maximum decreases: 37+3% and 74+3%, respectively) and conductances (maximum decreases: 32+5% and 72+3%, respectively). Neither SB224289 nor BRL15572 signi®cantly aected the increases in nutrient blood¯ow and conductance.
Eect of SB224289 on noradrenaline-induced changes in heart rate, mean arterial blood pressure and total carotid blood¯ow and conductance
As shown in Figure 3 , bolus injections of noradrenaline (0.1 ± 3 mg kg 71 , i.v.) produced dose-dependent increases (with maximum changes) in heart rate (+82+7%), mean arterial blood pressure (+31+2%) and total carotid blood¯ow (+26+5%) without aecting total carotid vascular conductance (maximum change: +4+1%). The maximum changes by noradrenaline remained either unchanged (heart rate, 76+3%; mean arterial blood pressure, 43+4%; total carotid vascular conductance, 5+4%) or were even enhanced (total carotid blood¯ow, 47+8%) after SB224289 (3 mg kg 71 , i.v.).
Discussion
General
We have previously shown that sumatriptan decreases porcine carotid blood¯ow by a selective vasoconstriction of cranial arteriovenous anastomoses (Den Boer et al., 1991) . The drug seems to exert this response via 5-HT 1B/1D receptors, since GR127935, a selective antagonist at these 5-HT 1 receptor subtypes (Clitherow et al., 1994; Pauwels, 1996; Skingle et al., 1996) , was able to abolish the sumatriptan-induced responses (De Vries et al., 1996) . The recent availability of silent selective antagonists for the 5-HT 1B (SB224289) and 5-HT 1D (BRL15572) receptors led us to further analyse the nature of the receptors mediating these responses. The present study in anaesthetized pigs clearly showed that the sumatriptaninduced carotid arteriovenous anastomotic constriction was potently and speci®cally antagonized in a dose-dependent manner by the selective 5-HT 1B receptor antagonist SB224289, but not by the selective 5-HT 1D receptor antagonist BRL15572. Apart from the implications discussed below, these data indicate that the vasoconstrictor response to sumatriptan on porcine carotid arteriovenous anastomoses is mainly mediated by 5-HT 1B receptors.
Systemic and carotid haemodynamic eects of vehicle, SB224289 and BRL15572
Statistically signi®cant changes were noticed only in the group that received the lower dose (1 mg kg 71 ) of SB224289. A moderate increase in mean arterial blood pressure and a vasoconstrictor eect in the carotid vasculature, con®ned to the arteriovenous anastomotic fraction, was observed. We do not have a clear explanation for this, but it is interesting to note that the 5-HT 1B/1D receptor antagonist GR127935 also 5-HT 1B receptors in the porcine carotid vascular bedconstricts porcine arteriovenous anastomoses, but, in contrast to SB224289, decreases blood pressure (De Vries et al., 1996) . Whereas the GR127935-induced carotid vasoconstriction may be related to its intrinsic activity at the h5-HT 1B receptor (Pauwels, 1996; Selkirk et al., 1998) , this seems unlikely in the case of SB224289, because this compound rather behaves as an inverse agonist at this receptor (Selkirk et al., 1998) .
Systemic haemodynamic eects induced by sumatriptan in animals treated with vehicle, SB224289 or BRL15572
Sumatriptan caused a small bradycardiac and hypotensive eect, similar to that reported earlier (De Vries et al., 1996) . This seems to be a class eect, since several other triptans also display this property (Saxena et al., 1997a; De Vries et al., 1998b; Willems et al., 1998) . The mechanism involved in the hypotensive and bradycardiac action of sumatriptan is not clear, but may involve sympathoinhibition either at the level of ganglia, neurovascular junction (Jones et al., 1995; VillaloÂ n et al., 1998) or perhaps within the central nervous system (see Saxena & VillaloÂ n, 1990) ; the latter mechanism seems unlikely on the basis of poor central penetration of sumatriptan. The hypotensive response to sumatriptan was unaected by GR127935 (De Vries et al., 1996) , but potentiated by the 5-HT 1B receptor antagonist SB224289 (Table 3 ), suggesting that sumatriptan simultaneously stimulates a systemic vasodilator and vasoconstrictor mechanism, of which the latter is amenable to blockade by SB224289. The sumatriptan-induced systemic dilatation may involve sympathoinhibition mediated by the 5-ht 1F receptor, for which SB224289 displays a very low and GR127935 only a moderate anity (see Table 1 ); this possibility requires further investigation. Whatever the mechanism, this eect of sumatriptan is clinically of little relevance. Sumatriptan (MacIntyre et al., 1993) as well as other similar drugs such as rizatriptan (Sciberraset al., 1997) , alniditan (Goldstein et al., 1996) and zolmitriptan (Seaber et al., 1996) produce increases rather than decreases in blood pressure in humans.
Carotid haemodynamics
Sumatriptan decreased total carotid blood¯ow, mainly due to a potent vasoconstrictor action on the cephalic arteriovenous anastomoses. The eect was similar to that observed earlier with this antimigraine agent (Den Boer et al., 1991; De Vries et al., 1996) . In animals treated with 1 mg kg 71 of the 5-HT 1B receptor ligand SB224289, the sumatriptan-induced decreases in total carotid and carotid arteriovenous anastomotic blood ow were not much aected; only at 300 mg kg 71 of sumatriptan a signi®cant attenuation was observed (see Figure  1 ). However, as described above, in the presence of SB224289 an enhancement of the sumatriptan-induced hypotension was observed. The latter will decrease the carotid perfusion pressure and, consequently, may exaggerate decreases in blood ow, thereby masking possible inhibition of the sumatriptaninduced eects by SB224289. Indeed, the decreases in total carotid and carotid arteriovenous anastomotic conductance (where the changes in blood¯ow are corrected for changes in blood pressure) were potently antagonized, although not completely eliminated, in animals treated with 1 mg kg 71 SB224289 (Figure 3 ). In contrast, 1 mg kg 71 of the 5-HT 1 receptor antagonist BRL15572 did not aect the carotid vascular eects of sumatriptan in any way. As SB224289 and BRL15572 display similar anities at their respective receptors (Table 1) , the lack of inhibitory eects by BRL15572, combined with the potent blockade by SB224289 at similar doses, it is reasonable to assume that 5-HT 1B , but not 5-HT 1D receptors, are involved in the vasoconstriction of carotid arteriovenous anastomoses. Admittedly, this conclusion is based on the assumption that species dierences between the binding of SB224289 and BRL15572 to porcine and human 5-HT 1B and 5-HT 1D receptors do not play a major role.
Since a part of the sumatriptan-induced carotid arteriovenous anastomotic constriction persisted after 1 mg kg 71 of SB224289, it may suggest that other receptors/mechanisms may be involved. Notwithstanding, we have previously shown that 0.5 mg kg 71 , but not 0.25 mg kg 71 of the 5-HT 1B/1D receptor antagonist GR127935 was needed for a complete blockade of the sumatriptan-induced porcine carotid vasoconstrictor eects (De Vries et al., 1996) . In view of the 10 fold higher anity displayed at the h5-HT 1B receptor by GR127935 compared to SB224289 (Table 1) , it can be expected that higher doses of SB224289 are needed to bring about a complete blockade. Indeed, 3 mg kg 71 of SB224289 completely abolished all sumatriptan-induced carotid vascular eects. In keeping with this, we have previously shown that 3 ± 10 fold higher concentrations of SB224289 (De Vries et al., 1998a) than GR127935 (VillaloÂ n et al., 1996) were required to completely inhibit the canine external carotid vasoconstriction by sumatriptan.
In order to ascertain the speci®city of SB224289 (3 mg kg 71 ), we decided to study cardiovascular responses to noradrenaline before and after administration of the antagonist. As expected, noradrenaline produced short-lasting increases in mean arterial blood pressure, which were accompanied by increased heart rate, as the barore¯ex mediated bradycardia was absent due to vagotomy (see Homan & Lefkowitz, 1996) . Moreover, noradrenaline increased carotid blood¯ow, which was mainly due to the hypertensive eect, as carotid vascular conductance did not change in response to the drug, as shown earlier (Verdouw et al., 1984) . SB224289 did not attenuate these eects; in fact, the noradrenaline-induced hypertension was potentiated, probably resulting in an enhancement of the increases in carotid blood ow. Therefore, it is concluded that 3 mg kg 71 of SB224289 most likely produced a speci®c antagonism against the sumatriptan-induced eects. In keeping with this, SB224289 displays low anities at a-and b-adrenoceptors (Gaster et al., 1998) .
Taking the above into account, the present results imply that sumatriptan constricts porcine arteriovenous anastomoses primarily via the 5-HT 1B receptor, which in contrast to the 5-HT 1D receptor is abundantly expressed on vascular smooth muscle (Ullmer et al., 1995; Bouchelet et al., 1996; Longmore et al., 1997) . Moreover, the results obtained in this study imply that the so-called 5-HT 1 -like receptor mediating vascular smooth muscle contraction , including porcine carotid arteriovenous anastomotic constriction (Den Boer et al., 1991) , is most likely to be identical to the 5-HT 1B receptor. This is also shown in the isolated human temporal artery (Verheggen et al., 1998) and the canine external carotid vascular bed (De Vries et al., 1998a) . Additionally, in view of the complete blockade by SB224289 and the highly selective nature of the compound, it seems unlikely that the other known 5-HT 1 subtypes (5-HT 1A , 5-ht 1E and 5-ht 1F ) are involved in the sumatriptan-induced carotid vascular eects. Thus, intracarotid infusions of LY344864 (1 ± 3100 mg min 71 ), a selective 5-ht 1F receptor agonist (Phebus et al., 1997) , does not produce vasoconstriction in the canine external carotid vascular bed (VillaloÂ n et al., 1999) . Also, mRNAs for 5-HT 1A and 5-ht 1E receptor have not been detected in the vascular smooth muscle (Ullmer et al., 1995) .
In conclusion, the results of the present experiments show that the constriction of porcine carotid arteriovenous anastomoses by the 5-HT 1 receptor agonist sumatriptan, being antagonized by the selective 5-HT 1B receptor antagonist SB224289, but not by the 5-HT 1D receptor ligand BRL15572, is predominantly mediated by 5-HT 1B receptors. In view of the putative pathophysiological role of arteriovenous anastomotic dilatation in migraine (see Heyck, 1969; Saxena, 1995) , the constriction of these nonnutrient vessels by sumatriptan via a 5-HT 1B receptor mechanism may be, at least partly, responsible for the therapeutic eect of the drug in migraine.
